The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.
This video provides information on how to administer directly observe therapy (DOT).
This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).
This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.
This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the testing and treatment of latent tuberculosis.
This fact sheet provides information regarding the QuantiFERON®-TB Gold In-Tube Test.
This fact sheet provides information regarding the QuantiFERON®-TB Gold In-Tube Test.
This fact sheet provides information regarding the QuantiFERON®-TB Gold In-Tube Test.
This report provides surveillance data, concise summaries of core program activities, and highlights for 2015.
This hospital discharge approval request form is required in New York City as New York City Health Code mandates health care providers to obtain approval
from the New York City Department of Health & Mental Hygiene (DOHMH) before discharging infectious TB patients from the hospital.
